China SXT Pharmaceuticals (SXTC) Short Interest Ratio & Short Volume → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free SXTC Stock Alerts $1.05 -0.11 (-9.48%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends China SXT Pharmaceuticals Short Interest DataCurrent Short Interest19,600 sharesPrevious Short Interest14,400 sharesChange Vs. Previous Month+36.11%Dollar Volume Sold Short$21,364.00Short Interest Ratio0.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares460,000 sharesFloat Size547,900 sharesShort Percent of Float3.58%Today's Trading Volume498,927 sharesAverage Trading Volume538,906 sharesToday's Volume Vs. Average93% Short Selling China SXT Pharmaceuticals ? Sign up to receive the latest short interest report for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSXTC Short Interest Over TimeSXTC Days to Cover Over TimeSXTC Percentage of Float Shorted Over Time Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. China SXT Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202419,600 shares $21,364.00 +36.1%3.6%0 $1.09 4/30/202414,400 shares $15,264.00 -77.4%2.6%0 $1.06 4/15/202463,600 shares $74,412.00 +142.8%11.6%0.1 $1.17 3/31/202426,200 shares $44,016.00 +376.4%4.8%0 $1.68 3/15/20245,500 shares $9,570.00 -93.4%1.0%0 $1.74 2/29/202482,800 shares $163,116.00 +145.0%15.1%0.1 $1.97 Get the Latest News and Ratings for SXTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/202433,800 shares $73,684.00 -59.3%6.2%0 $2.18 1/31/202483,000 shares $161,020.00 +538.5%14.8%0.1 $1.94 1/15/202413,000 shares $24,440.00 +100.0%2.3%0 $1.88 12/31/20236,500 shares $25,805.00 -67.3%1.2%0 $3.97 12/15/202319,900 shares $38,805.00 -33.7%3.6%0.1 $1.95 11/30/202330,000 shares $63,600.00 +67.6%5.3%0.2 $2.12 11/15/202317,900 shares $42,602.00 -70.2%3.2%0.1 $2.38 10/31/202360,100 shares $129,221.01 -21.4%10.7%0.3 $2.15 10/15/202376,500 shares $225,675.00 +948.0%13.6%0.3 $2.95 9/30/20237,300 shares $22,447.50 -98.7%0.1%0 $3.08 9/15/2023575,400 shares $75,780.18 +99.7%4.6%0.1 $0.13 8/31/2023288,100 shares $32,555.30 +553.3%2.4%0.1 $0.11 8/15/202344,100 shares $6,513.57 -61.1%0.4%0 $0.15 7/31/2023113,300 shares $23,113.20 +18.1%1.0%0.2 $0.20 7/15/202395,900 shares $18,796.40 -8.2%1.1%0.1 $0.20 6/30/2023104,500 shares $24,557.50 +5.9%1.2%0.1 $0.24 6/15/202398,700 shares $23,737.35 +4.0%1.2%0.1 $0.24 5/31/202394,900 shares $19,255.21 -69.1%1.1%0.2 $0.20 5/15/2023307,300 shares $69,019.27 +1,034.0%3.6%0.5 $0.22 4/30/202327,100 shares $6,720.80 +942.3%0.3%0 $0.25 4/15/20232,600 shares $621.14 -83.5%0.1%0 $0.24 3/31/202315,800 shares $4,480.88 +13.7%0.5%0 $0.28 3/15/202313,900 shares $4,075.48 -68.3%0.5%0 $0.29 2/28/202343,800 shares $17,182.74 -25.5%1.4%0.1 $0.39 2/15/202358,800 shares $28,812.00 -18.0%1.8%0.1 $0.49 1/31/202371,700 shares $40,144.83 -10.7%2.3%0.1 $0.56 1/15/202380,300 shares $47,377.00 -22.8%1.7%0.1 $0.59 12/30/2022104,000 shares $56,368.00 -68.0%2.2%0.2 $0.54 12/15/2022324,500 shares $195,803.30 +587.5%7.6%0.6 $0.60 11/30/202247,200 shares $33,035.28 +193.2%2.2%0.1 $0.70 11/15/202216,100 shares $10,787.00 -17.0%0.7%0 $0.67 10/31/202219,400 shares $11,640.00 -62.4%0.9%0 $0.60 10/15/202251,600 shares $35,088.00 -16.9%2.4%0.1 $0.68 9/30/202262,100 shares $47,817.00 -50.2%2.8%0.1 $0.77The only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here 9/15/2022124,600 shares $139,552.00 -11.3%5.7%0.3 $1.12 8/31/2022140,400 shares $197,262.00 +345.7%6.4%0.3 $1.41 8/15/202231,500 shares $51,345.00 +34.6%1.3%0.2 $1.63 7/31/202223,400 shares $34,164.00 -67.1%1.0%0.2 $1.46 7/15/202271,100 shares $129,402.00 +17.5%4.1%0.7 $1.82 6/30/202260,500 shares $105,875.00 -38.3%3.5%0.6 $1.75 6/15/202298,100 shares $162,846.00 +42.4%5.6%0.3 $1.66 5/31/202268,900 shares $144,690.00 +98.0%4.0%0.2 $2.10 5/15/202234,800 shares $115,118.40 -95.9%2.0%0.1 $3.31 4/30/2022856,400 shares $183,440.88 +7.5%N/A0.1 $0.21 4/15/2022796,400 shares $175,208.00 -84.4%N/A0.1 $0.22 3/31/20225,100,000 shares $1.43 million +1,933.5%38.7%0.5 $0.28 3/15/2022250,800 shares $42,134.40 +19.0%1.9%0 $0.17 2/28/2022210,800 shares $45,954.40 -56.7%1.6%0 $0.22 2/15/2022487,200 shares $89,157.60 -34.7%3.7%0.2 $0.18 1/31/2022746,200 shares $160,656.86 +294.6%5.7%0.3 $0.22 1/15/2022189,100 shares $101,735.80 -32.3%1.4%0.1 $0.54 12/31/2021279,200 shares $181,563.76 +50.6%2.3%0.5 $0.65 12/15/2021185,400 shares $119,564.46 -47.3%1.5%0.4 $0.64 11/30/2021351,800 shares $248,529.46 -31.1%2.9%0.7 $0.71 11/15/2021510,500 shares $433,925.00 -16.6%4.1%1.1 $0.85 10/29/2021612,000 shares $581,767.20 +107.0%5.0%1.3 $0.95 10/15/2021295,600 shares $275,114.92 -18.4%2.4%0.6 $0.93 9/30/2021362,300 shares $373,169.00 -24.4%2.9%0.2 $1.03 9/15/2021479,400 shares $498,576.00 -10.0%3.9%0.2 $1.04 8/31/2021532,900 shares $623,493.00 -3.0%4.3%0.2 $1.17 8/13/2021549,200 shares $648,056.00 -18.8%4.4%0.2 $1.18 7/30/2021675,900 shares $844,875.00 +38.9%5.1%0.3 $1.25 7/15/2021486,600 shares $729,900.00 -19.5%3.6%0.2 $1.50 6/30/2021604,700 shares $876,815.00 +19.2%4.5%2.5 $1.45 6/15/2021507,300 shares $715,293.00 -5.0%3.8%1.4 $1.41 5/28/2021533,900 shares $688,731.00 -3.2%4.0%0.9 $1.29 5/14/2021551,400 shares $634,110.00 +2.9%4.1%0.8 $1.15 4/30/2021536,100 shares $771,984.00 -19.7%4.0%0.5 $1.44 4/15/2021667,500 shares $987,900.00 +25.5%5.0%0.4 $1.48 3/31/2021531,700 shares $988,962.00 +21.1%4.0%0.2 $1.86 3/15/2021438,900 shares $877,800.00 +34.1%3.3%0.2 $2.00 2/26/2021327,300 shares $680,784.00 -77.3%2.4%0.1 $2.08 2/12/20211,440,000 shares $1.48 million +15.2%N/A0.6 $1.03 1/29/20211,250,000 shares $841,750.00 +15.7%N/A0.2 $0.67 1/15/20211,080,000 shares $683,532.00 +38.2%N/A0.2 $0.63 12/31/2020781,700 shares $269,686.50 +334.5%N/A0.2 $0.35 12/15/2020179,900 shares $55,265.28 +32.4%N/A0.1 $0.31 11/30/2020135,900 shares $40,076.91 +27.5%N/A0 $0.29 11/15/2020106,600 shares $27,982.50 -78.7%N/A0.1 $0.26 10/30/2020500,400 shares $146,367.00 +220.8%N/A0.2 $0.29 10/15/2020156,000 shares $42,057.60 +24.2%N/A0.1 $0.27 9/30/2020125,600 shares $30,746.88 -81.3%N/A0 $0.24 9/15/2020671,200 shares $171,558.72 +377.7%N/A0.2 $0.26 8/31/2020140,500 shares $42,178.10 -60.4%N/A0 $0.30The only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here 8/14/2020354,600 shares $131,131.08 +158.8%N/A0.1 $0.37 7/31/2020137,000 shares $54,334.20 +2.2%N/A0 $0.40 7/15/2020134,000 shares $58,263.20 -84.3%1.0%0 $0.43 6/30/2020853,600 shares $469,053.20 +723.9%6.3%0.1 $0.55 6/15/2020103,600 shares $46,640.72 -53.8%0.8%0 $0.45 5/29/2020224,200 shares $88,693.52 -73.5%1.7%0.1 $0.40 5/15/2020844,700 shares $372,259.29 +50.1%6.2%0.4 $0.44 4/30/2020562,800 shares $247,632.00 +25.1%4.2%0.3 $0.44 4/15/2020449,800 shares $193,414.00 -29.1%3.3%0.2 $0.43 3/31/2020634,600 shares $272,878.00 +21.3%4.7%0.3 $0.43 3/13/2020523,200 shares $204,048.00 +628.7%3.9%0.2 $0.39 2/28/202071,800 shares $44,516.00 +126.5%0.5%0 $0.62 2/14/202031,700 shares $27,896.00 -63.7%0.2%0 $0.88 1/31/202087,200 shares $78,480.00 -26.4%0.7%0.1 $0.90 1/15/2020118,500 shares $113,760.00 -15.4%0.9%0.2 $0.96 12/31/2019140,000 shares $124,600.00 +232.5%1.1%0.7 $0.89 8/15/2019278,900 shares $719,562.00 -7.7%3.3%5.1 $2.58 SXTC Short Interest - Frequently Asked Questions What is China SXT Pharmaceuticals' current short interest? Short interest is the volume of China SXT Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 19,600 shares of SXTC short. 3.58% of China SXT Pharmaceuticals' shares are currently sold short. Learn More on China SXT Pharmaceuticals' current short interest. What is a good short interest percentage for China SXT Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.58% of China SXT Pharmaceuticals' floating shares are currently sold short. Is China SXT Pharmaceuticals' short interest increasing or decreasing? China SXT Pharmaceuticals saw a increase in short interest in May. As of May 15th, there was short interest totaling 19,600 shares, an increase of 36.1% from the previous total of 14,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is China SXT Pharmaceuticals' float size? China SXT Pharmaceuticals currently has issued a total of 460,000 shares. Some of China SXT Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. China SXT Pharmaceuticals currently has a public float of 547,900 shares. How does China SXT Pharmaceuticals' short interest compare to its competitors? 3.58% of China SXT Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to China SXT Pharmaceuticals: Galmed Pharmaceuticals Ltd. (1.26%), Clearmind Medicine Inc. (8.29%), Qualigen Therapeutics, Inc. (1.31%), Notable Labs, Ltd. (0.38%), GRI Bio, Inc. (0.65%), Lucy Scientific Discovery Inc. (2.73%), 180 Life Sciences Corp. (3.35%), Dermata Therapeutics, Inc. (1.46%), NeuBase Therapeutics, Inc. (0.51%), PainReform Ltd. (1.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short China SXT Pharmaceuticals stock? Short selling SXTC is an investing strategy that aims to generate trading profit from China SXT Pharmaceuticals as its price is falling. SXTC shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against China SXT Pharmaceuticals? A short squeeze for China SXT Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SXTC, which in turn drives the price of the stock up even further. How often is China SXT Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SXTC, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Galmed Pharmaceuticals Short Interest Clearmind Medicine Short Interest Qualigen Therapeutics Short Interest Notable Labs Short Interest GRI Bio Short Interest Lucy Scientific Discovery Short Interest 180 Life Sciences Short Interest Dermata Therapeutics Short Interest NeuBase Therapeutics Short Interest PainReform Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SXTC) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWho are Nvidia’s New Silent Partners?Weiss Ratings[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
